HMG-CoA reductase inhibitor augments the serum total cholesterol-lowering effect of human adipose tissue-derived multilineage progenitor cells in hyperlipidemic homozygous Watanabe rabbits

Biochemical and Biophysical Research Communications

Volumn 412, Issue 1, 2011, Pages 50-54

  Saga, Ayami ^a   Okura, Hanayuki ^a   Soeda, Mayumi ^a   Tani, Junko ^a   Fumimoto, Yuichi ^a   Komoda, Hiroshi ^a   Moriyama, Mariko ^a,b   Moriyama, Hiroyuki ^b   Yamashita, Shizuya ^c   Ichinose, Akihiro ^d   Daimon, Takashi ^e   Hayakawa, Takao ^b   Matsuyama, Akifumi ^a  

^a FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KOBE UNIVERSITY HOSPITAL   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

ADMPC; Cell therapy; Cholesterol; HMG CoA reductase inhibitor; Pravastatin; WHHL

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL THERAPY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LOWERING EFFECT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; STEM CELL; STEM CELL TRANSPLANTATION;

ADIPOSE TISSUE; ADULT; ANIMALS; CELL LINEAGE; CHOLESTEROL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; MIDDLE AGED; PRAVASTATIN; RABBITS; STEM CELL TRANSPLANTATION; STEM CELLS; YOUNG ADULT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 80051798604     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.035     Document Type: Article

References (27)

1. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
2. Havel R.J., Yamada N., Shames D.M. Watanabe heritable hyperlipidemic rabbit. Animal model for familial hypercholesterolemia. Arteriosclerosis 1989, 9(1):133-138.
3. Yamamoto T., Bishop R.W., Brown M.S., Goldstein J.L., Russell D.W. Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit. Science 1986, 32:1230-1237.
4. Maruyama T., Yamashita S., Matsuzawa Y., Bujo H., Takahashi K., Saito Y., Ishibashi S., Ohashi K., Shionoiri F., Gotoda T., Yamada N., Kita T. Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan. Mutations in Japanese subjects with primary hyperlipidemia - results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996. J. Atheroscler. Thromb. 2004, 11:131-145.
5. Yamashita S., Bujo H., Arai H., Harada-Shiba M., Matsui S., Fukushima M., Saito Y., Kita T., Matsuzawa Y. Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan. J. Atheroscler. Thromb. 2008, 15:292-303.
6. Chowdhury J.R., Grossman M., Gupta S., Chowdhury N.R., Baker J.R., Wilson J.M. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 1991, 254:1802-1805.
7. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 1993, 92:883-893.
8. Kozarsky K.F., McKinley D.R., Austin L.L., Raper S.E., Stratford-Perricaudet L.D., Wilson J.M. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 1994, 269:13695-13702.
9. Wilson J.M., Chowdhury N.R., Grossman M., Wajsman R., Epstein A., Mulligan R.C., Chowdhury J.R. Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc. Natl. Acad. Sci. USA 1990, 87:8437-8441.
10. Gunsalus J.R., Brady D.A., Coulter S.M., Gray B.M., Edge A.S. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation. Nat. Med. 1997, 3:48-53.
11. Tejera M.L., Cienfuegos J.A., Maganto P., Pardo F., Santamaria L., Codesal J., De Andres S., Hernandez J.L., Castillo-Olivares J.L. Reduction of cholesterol levels following liver cell grafting in hyperlipidemic (WHHL) rabbits. Transplant. Proc. 1992, 24:160-161.
12. Wang J., Pollak R., Bartholomew A. Sustained reduction of serum cholesterol levels following allo-transplantation of parenchymal hepatocytes in Watanabe rabbits. Transplant. Proc. 1991, 23:894-895.
13. Wiederkehr J.C., Kondos G.T., Pollak R. Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit. Transplantation 1990, 50:466-471.
14. Okura H., Komoda H., Saga A., Kakuta-Yamamoto A., Hamada Y., Fumimoto Y., Lee C.M., Ichinose A., Sawa Y., Matsuyama A. Properties of hepatocyte-like cell clusters from human adipose tissue-derived mesenchymal stem cells. Tissue Eng. Part C Methods 2010, 16:761-770.
15. Okura H., Saga A., Fumimoto Y., Soeda M., Moriyama M., Moriyama H., Nagai K., Lee C.M., Yamashita S., Ichinose A., Hayamakawa T., Matsuyama A. Transplantation of human adipose tissue-derived multilineage progenitor cells reduces serum cholesterol in hyperlipidemic Watanabe rabbits. Tissue Eng. Part C Methods 2011, 17:145-154.
16. Seo M.J., Suh S.Y., Bae Y.C., Jung J.S. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem. Biophys. Res. Commun. 2005, 328:258-264.
17. Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Quinn G., Okochi H., Ochiya T. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 2007, 46:219-228.
18. Komoda H., Okura H., Lee C.M., Sougawa N., Iwayama T., Hashikawa T., Saga A., Yamamoto A., Ichinose A., Murakami S., Sawa Y., Matsuyama A. Reduction of Nglycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies. Tissue Eng. Part A 2010, 16:1143-1155.
19. Okura H., Matsuyama A., Lee C.M., Saga A., Kakuta-Yamamoto A., Nagao A., Sougawa N., Sekiya N., Takekita K., Shudo Y., Miyagawa S., Komoda H., Okano T., Sawa Y. Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model. Tissue Eng. Part C Methods 2010, 16:417-425.
20. Nozaki S., Nakagawa T., Nakata A., Yamashita S., Kameda-Takemura K., Nakamura T., Keno Y., Tokunaga K., Matsuzawa Y. Effects of pravastatin on plasma and urinary mevalonate concentrations in subjects with familial hypercholesterolaemia: a comparison of morning and evening administration. Eur. J. Clin. Pharmacol. 1996, 49:361-364.
21. Bjorntorp P., Karlsson M., Pertoft H., Pettersson P., Sjostrom L., Smith U. Isolation and characterization of cells from rat adipose tissue developing into adipocytes. J. Lipid Res. 1978, 19:316-324.
22. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 2007, 100:1249-1260.
23. Dowell F.J., Hamilton C.A., Lindop G.B., Reid J.L. Development and progression of atherosclerosis in aorta from heterozygous and homozygous WHHL rabbits. Effects of simvastatin treatment. Arterioscler. Thromb. Vasc. Biol. 1995, 15:1152-1160.
24. Harsch M., Gebhardt A., Reymann A., Lang G., Schliack M., Löser R., Braesen J.H., Niendorf A. Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits. Br. J. Pharmacol. 1998, 124:277-282.
25. Kuroda M., Matsumoto A., Itakura H., Watanabe Y., Ito T., Shiomi M., Fukushige J., Nara F., Fukami M., Tsujita Y. Effects of pravastatin sodium alone and in combination with cholestyramine on hepatic, intestinal and adrenal low density lipoprotein receptors in homozygous Watanabe heritable hyperlipidemic rabbits. Jpn. J. Pharmacol. 1992, 59:65-70.
26. Shiomi M., Ito T., Watanabe Y., Tsujita Y., Kuroda M., Arai M., Fukami M., Fukushige J., Tamura A. Suppression of established atherosclerosis and xanthomas in mature WHHL rabbit by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine. Atherosclerosis 1990, 83:69-80.
27. Steinberg D., Witztum J.L. Current concepts. Lipoproteins and atherogenesis. JAMA 1990, 264:3047-3052.